These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9639255)

  • 1. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry.
    Reum T; Fink H; Marsden CA; Morgenstern R
    Neuropeptides; 1998 Apr; 32(2):161-6. PubMed ID: 9639255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholecystokinin increases extracellular dopamine overflow in the anterior nucleus accumbens via CCK(B) receptors in the VTA assessed by in vivo voltammetry.
    Reum T; Schäfer U; Marsden CA; Fink H; Morgenstern R
    Neuropeptides; 1997 Feb; 31(1):82-8. PubMed ID: 9574843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of administration of cholecystokinin into the VTA on DA overflow in nucleus accumbens and amygdala of freely moving rats.
    Hamilton ME; Freeman AS
    Brain Res; 1995 Aug; 688(1-2):134-42. PubMed ID: 8542299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABA(A) receptor blockade in the anterior ventral tegmental area increases extracellular levels of dopamine in the nucleus accumbens of rats.
    Ikemoto S; Kohl RR; McBride WJ
    J Neurochem; 1997 Jul; 69(1):137-43. PubMed ID: 9202304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.
    Weiss F; Ettenberg A; Koob GF
    Psychopharmacology (Berl); 1989; 99(3):409-15. PubMed ID: 2574480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cholecystokinin-8 microinjection into ventral tegmental area on dopamine release in nucleus accumbens of rats: an in vivo voltammetric study.
    Xie JX; Tang M; Zhang C
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Feb; 25(2):427-34. PubMed ID: 11294486
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic administration of CCK-8S, but not CCK-4, enhances dopamine turnover in the posterior nucleus accumbens: a microdialysis study in freely moving rats.
    Kariya K; Tanaka J; Nomura M
    Brain Res; 1994 Sep; 657(1-2):1-6. PubMed ID: 7820607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regional effects of apomorphine on rat brain cholecystokinin-8 like immunoreactivity following electrolytic lesions of the ventral tegmental area.
    Fukamauchi F; Takahashi R
    Neuropeptides; 1988; 11(2):63-7. PubMed ID: 3368037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of GABA and cholinergic receptors in the nucleus accumbens on feedback control of somatodendritic dopamine release in the ventral tegmental area.
    Rahman S; McBride WJ
    J Neurochem; 2002 Feb; 80(4):646-54. PubMed ID: 11841572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxytocin injected into the ventral tegmental area induces penile erection and increases extracellular dopamine in the nucleus accumbens and paraventricular nucleus of the hypothalamus of male rats.
    Melis MR; Melis T; Cocco C; Succu S; Sanna F; Pillolla G; Boi A; Ferri GL; Argiolas A
    Eur J Neurosci; 2007 Aug; 26(4):1026-35. PubMed ID: 17672853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
    Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
    Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitization of ventral tegmental area dopamine neurons to the stimulating effects of ethanol.
    Ding ZM; Rodd ZA; Engleman EA; McBride WJ
    Alcohol Clin Exp Res; 2009 Sep; 33(9):1571-81. PubMed ID: 19485970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiological effects of cholecystokinin octapeptide on identified rat nigrostriatal dopaminergic neurons.
    Freeman AS; Chiodo LA
    Brain Res; 1988 Jan; 439(1-2):266-74. PubMed ID: 3359189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noradrenergic Modulation of Dopamine Transmission Evoked by Electrical Stimulation of the Locus Coeruleus in the Rat Brain.
    Park JW; Bhimani RV; Park J
    ACS Chem Neurosci; 2017 Sep; 8(9):1913-1924. PubMed ID: 28594540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute and long-term changes in the mesolimbic dopamine pathway after systemic or local single nicotine injections.
    Ferrari R; Le Novère N; Picciotto MR; Changeux JP; Zoli M
    Eur J Neurosci; 2002 Jun; 15(11):1810-8. PubMed ID: 12081661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Nisell M; Nomikos GG; Svensson TH
    Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CCK/dopamine interactions in Fawn-Hooded and Wistar-Kyoto rat brain.
    Lodge DJ; Short JL; Mercer LD; Beart PM; Lawrence AJ
    Peptides; 2000 Mar; 21(3):379-86. PubMed ID: 10793220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholecystokinin octapeptide and caerulein injection into the dorsomedial nucleus accumbens potentiate apomorphine-induced jaw movements in rats.
    Koshikawa N; Kikuchi de Beltrán K; Saigusa T; Kobayashi M; Stephenson JD
    Eur J Pharmacol; 1991 Dec; 209(1-2):75-80. PubMed ID: 1814762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apomorphine affects cholecystokinin content via preferentially D1 or D2 dopamine receptor according to the regions of the rat brain.
    Yoshikawa T; Fukamauchi F; Shibuya H; Takahashi R
    Neuropeptides; 1989; 13(2):103-5. PubMed ID: 2567971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.